CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the <i>3xTg</i> Mouse Model of Alzheimer's Disease by Multiple Actions in the Pathology.

Int J Mol Sci · 2025 · PMC11818425 · PMID 39941068

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

almost significantp = 0.052so close (0.05 < p ≤ 0.1)

For GR activity, the statistical analysis revealed a significant main effect for the group, which was almost significant (H = 5.655, p = 0.052).

also in 1,858 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the &lt;i&gt;3xTg&lt;/i&gt; Mouse Model of Alzheimer's Disease by Multiple Actions in the Pathology.

The sentences

CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the <i>3xTg</i> Mouse Model of Alzheimer's Disease by Multiple Actions in the Pathology.